Author:
Liu Wanqing,Wu Xiaolin,Zhang Wei,Montenegro Raquel C.,Fackenthal Donna Lee,Spitz Jared A.,Huff Lyn Mickley,Innocenti Federico,Das Soma,Cook, Edwin H.,Cox Nancy J.,Bates Susan E.,Ratain Mark J.
Publisher
American Association for Cancer Research (AACR)
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel 2‐[thio]acetamide linked quinazoline/1,2,4‐triazole/chalcone hybrids: Design, synthesis, and anticancer activity as EGFR inhibitors and apoptotic inducers;Archiv der Pharmazie;2024-04-09
2. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & −191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA;Experimental Oncology;2023-10-11
3. Liquid biopsy: an innovative and reliable method for detecting not only somatic, but also germline mutations in patients with colorectal and non-small cell lung carcinoma;Biotechnology & Biotechnological Equipment;2023-08-26
4. Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives;Frontiers in Pharmacology;2021-08-27
5. mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications;Frontiers in Oncology;2021-03-26